From our massive range of cancer fighting medicines, we have this 2mg Bortezomib Injection IP which is used for the treatment of multiple myeloma and mantle cell lymphoma. The injection has been precisely formulated by the manufacturers, following the guidelines of international standards and medical association of India. Bortecad for bolus intravenous injection is meant for single use only. As taken in correct dosage and at the correct time it has to be taken, this medication works to stop or slow down the growth of cancer cells. The dosage is decided by the doctor based on the condition and the dosage could be changed from time to time. The benefit of the medication might be felt after several weeks or months. Keeping a professional approach, we deal with the manufacturers who are well-known in the domain, and procure highly effective, antineoplastic agent, 2mg Bortezomib Injection IP at the market leading rates, so as to serve the needs of the end customers well.